Atorvastatin is a pharmaceutical raw material in the production of atorvastatin drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Scope of the Report: This report focuses on the Atorvastatin in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Segment by Manufacturers, this report covers Pfizer DSM Sinochem Pharmaceuticals Ind-Swift Cadila Pharmaceuticals Morepen Sun Pharmaceutical Industries MSN Laboratories Dr. Reddy?s Teva Pharmaceutical Industries Apotex Pharmachem Zheijang Neo-Dankon Pharmaceutical Ningbo Menovo Pharmaceuticals Group Jialin Pharmaceutical Topfond Zhejiang Hisun Pharmacutical Zhejiang Hongyuan Pharmaceutical Hubei Yitai Pharmaceutical Jiangsu Hengrui Medicine. Market Segment by Regions (Province), covering South China Southwest China East China Northeast China North China Market Segment by Type, covers Chemical Synthesis Biocatalysis Market Segment by Applications, can be divided into Tablet (including dispersible tablet and general tablet) Capsule Others There are 18 Chapters to deeply display the China Atorvastatin market. Chapter 1, to describe Atorvastatin Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Atorvastatin, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4,to show the China market by Regions (Province),covering South China,East China,Southwest China,North China,Northeast China,Northwest China and Central China,with sales, price,revenue and market share of Atorvastatin,for each region,from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7,8,9,10,11,12 and 13 to analyze the key Province by Type and Application,covering South China,East China,Southwest China,North China,Northwest China,Central China and Northeast China,with sales,revenue and market share by types and applications; Chapter 14, Atorvastatin market forecast, by Regions (Province), type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 17, to describe sales channel, distributors, traders, dealers etc. Chapter 18, to describe Atorvastatin Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Atorvastatin Introduction 1.2 Market Analysis by Type 1.2.1 Chemical Synthesis 1.2.2 Biocatalysis 1.3 Market Analysis by Applications 1.3.1 Tablet (including dispersible tablet and general tablet) 1.3.2 Capsule 1.3.3 Others 1.4 Market Analysis by Regions (Province) 1.4.1 South China S
